Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other ...

For years, researchers have suspected that a hormone called relaxin could be an effective treatment for certain ...

CDK 4/6 inhibitors (CDK4/6i) remain part of the standard first-line treatment for patients with hormone receptor–positive metastatic breast cancer, offering demonstrable improvements in both ...

Explore new strategies for treating resistant lung cancer. Discover how blocking growth hormone receptors may improve ...

ORLANDO -- An investigational triple-hormone receptor agonist improved metabolic profiles of people with obesity with or without type 2 diabetes, an exploratory biomarker analysis of a phase II trial ...

Differences in how gut cells respond to hormones may help to explain why women experience more frequent and severe gut pain than men do, a study in mice suggests. Irritable bowel syndrome (IBS) ...

Faslodex (fulvestrant) is a prescription medicine used for people with certain types of breast cancer. Faslodex is given as an injection into the buttocks (gluteal area) by a health care provider in a ...

A new study is shining a light on a potential way to make treatments work better for one of the deadliest forms of cancer. Researchers at Ohio University have identified a protein that could be a ...

GLP-1s are building a reputation as "wonder drugs." First characterized for their ability to improve insulin release and ...